NEWSROOM

BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange

BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange

Strategic Audit Completion Set to Enhance BioStem Technologies' Market Position and Shareholder Value POMPANO BEACH, FLORIDA, April 24, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023. This completion is a significant step in the company’s strategy to uplist to a...

read more
BranchOut Food Announces Third Contract with Nation’s Largest Retailer, to Total $8M in Annualized Revenue

BranchOut Food Announces Third Contract with Nation’s Largest Retailer, to Total $8M in Annualized Revenue

New commitment valued at $300,000 brings total annualized value to over $8M BranchOut Food’s dried fruit products expected to enter 1,400 stores in September 2024 BEND, Ore., April 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced it has expanded its existing relationship with the nation’s largest retailer. The new agreement brings the total annualized value of commitments from the...

read more
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive

Data Solutions LAS VEGAS, NEVADA, April 23, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today that it’s introducing a state-of-the-art supercomputing network and comprehensive licensable dataset.  Avant will be collaborating with its technology partner, Wired4Tech, to launch these pivotal developments, which are...

read more
Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC

Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC

Rodedawg enters into 11 Billion dollar topical pain relief market COSTA MESA,‌ ‌CA‌, April 23,‌ ‌2024‌ ‌- Rodedawg International Industries, Inc. (OTC: RWGI) is pleased to announce the appointment of new officers to lead its subsidiary, Elixicure, Inc. Chris Swartz, CEO, states: “Last year, Rodedawg acquired Elixicure’s assets of brands, manufacturing equipment, trade secrets, and online stores. According to Future Market Insights research, as the world continues to face chronic pain disorder...

read more
SS Innovations International Announces Q1 2024 Company Updates

SS Innovations International Announces Q1 2024 Company Updates

Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, FL, April 22, 2024 - SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced its Q1 2024 Company updates. As of March 31, 2024, SS Innovations has completed a total of 32 successful installations of...

read more
PRISM MarketView – Biotech Breakfast 

PRISM MarketView – Biotech Breakfast 

Roche’s Alecensa Gets FDA Green Light; ImmunityBio Gains as PDUFA Date Approaches for Bladder Cancer Drug; Key Drug Trial Failures in 2024 New York, N.Y., April 22, 2024 - PRISM MarketView - Healthcare equities finished mostly higher after a very quiet trading session on Friday. The S&P 500 Healthcare Index closed up +0.32% versus the S&P 500 Index which lost (0.88%) and the XBI settled down (0.78%). A lack of momentum today left Roche stock up by just +0.95% following the FDA greenlit...

read more
PRISM MarketView – Weekly Market Report 

PRISM MarketView – Weekly Market Report 

PRISM Market Pulse: Market Tumbles Amid Fed's Rate Stance; Mixed Corporate Earnings Highlight Sector Struggles New York, N.Y., April 19, 2024 - PRISM MarketView - Equities were down in the morning and into midday as the major indices remain on track to notch their third straight week of declines. Fedspeak continues to support the “higher-for-longer” narrative with no urgency to cut rates which has created further sharp outflows and investor skepticism. The Street has taken investors’ pulses in...

read more
Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC

Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides 2nd Quarter Company Milestone Updates for April 2024

Cannabis Distribution Licensing Record Updated to Complete & Share Cancellation Moving Forward COSTA MESA,‌ ‌CA‌, April 19th,‌ ‌2024‌ ‌- Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the Company’s cannabis distribution license in Coachella, California, owned by its wholly-owned subsidiary, Parabola Mgmt. LLC, has been upgraded to “Record Complete” by the California Department of Cannabis Control. Chris Swartz, CEO, states, “On April 12th, 2024, we informed our...

read more
DRYWORLD and Renegade Territory Enter “Era-Defining” Partnership With Grammy-Award Winner, OPLUS

DRYWORLD and Renegade Territory Enter “Era-Defining” Partnership With Grammy-Award Winner, OPLUS

Collaboration marks DRYWORLD’s second partnership deal with Renegade Territory in 2024 SANTA BARBARA, CA, April 19, 2024 - DRYWORLD Brands Inc. (OTC: IBGR), a premium performance sports brand, is pleased to announce it has partnered with Renegade Territory to release a collection of soccer jerseys in collaboration with OPLUS, the Grammy award-winning musician hailing from Cali, Colombia. Osmar “OPLUS” Escobar is a highly successful artist, executive and songwriter with unparalleled...

read more
PRISM MarketView – Bio Investor Alert

PRISM MarketView – Bio Investor Alert

New York, N.Y., April 18, 2024 - PRISM MarketView - More than 83,000 new cases of bladder cancer are diagnosed in the US each year, and the illness is responsible for around 17,000 deaths annually. Urothelial carcinoma accounts for 90% of bladder cancers in the US and western Europe, and surgery, followed by chemotherapy or radiation is the current standard of care. There are 24 drugs approved by the FDA for bladder cancer, but due to invasive and life-changing surgical procedures, researchers...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850